- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/337 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 207/337
Total number of patents in this class: 138
10-year publication summary
|
12
|
6
|
11
|
9
|
18
|
9
|
7
|
11
|
5
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2714 |
9 |
| Syngenta Crop Protection AG | 6045 |
8 |
| ADT Pharmaceuticals, LLC | 13 |
8 |
| Temple University of the Commonwealth System of Higher Education | 613 |
6 |
| Board of Regents of the University of Nebraska | 757 |
5 |
| Sentinel Oncology Limited | 38 |
5 |
| University of Rochester | 1308 |
5 |
| Bayer Cropscience AG | 2039 |
4 |
| Bayer Animal Health GmbH | 221 |
4 |
| Orion Corporation | 620 |
4 |
| The Regents of the University of California | 19898 |
3 |
| VenatoRx Pharmaceuticals, Inc. | 86 |
3 |
| Rhizen Pharmaceuticals AG | 56 |
3 |
| CHDI Foundation, Inc. | 108 |
2 |
| Hawaii Biotech, Inc. | 23 |
2 |
| Matrix Laboratories Limited | 102 |
2 |
| Nippon Chemical Industrial Co., Ltd. | 282 |
2 |
| Proteostasis Therapeutics, Inc. | 70 |
2 |
| Rottapharm S.p.A. | 83 |
2 |
| Unity Biotechnology, Inc. | 78 |
2 |
| Other owners | 57 |